Phase
Condition
N/ATreatment
Computer assisted ambulatory electroencephalogram
Clinical Study ID
Ages 40-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria for EOAD patients will be recruited from the LEADS trial with the following:
40 to 64 years of age
Meets NIA-AA criteria for mild cognitive impairment (MCI) due to AD or probable ADdementia.
Have a global CDR score of ≤ 1.0
Have capacity to provide informed consent (ICF) or has a legal authorizedrepresentative or guardian who provides IC.
Amyloid positive status (PET scan with evidence of elevated amyloid)
Must have a study partner (informant) who spends a minimum average of 10 hours perweek with the participant (e.g., family member, significant other, friend, andcaregiver) who is generally aware of the participants' daily activities and canprovide information about the participant's cognitive and functional performance. Ifthe participant does not have a study partner who spends 10 face-to-face hours perweek, other arrangements for identifying a viable study partner will be granted on acase-by-case basis by the Site PI.
Not pregnant or lactating. Women must be two years post-menopausal, be surgicallysterile, or have a negative pregnancy test prior to each PET scan
Fluent in English.
Exclusion
Exclusion Criteria:
Meets core clinical criteria for non-AD dementia.
Two or more first degree relatives with a history of EOAD suggestive of autosomaldominant transmission, unless known pathogenic mutations in APP, PSEN1, PSEN2 havebeen excluded.
Known mutation in an ADAD gene (APP, PSEN1, PSEN2) or other autosomal dominant genesassociated with other neurodegenerative disorders.
MRI scans with evidence of infection or focal lesions, cortical strokes, multiplelacunes (single lacune is allowable unless it meets criteria for strategic lacuneaffecting cognition)
Any significant systemic illness or unstable medical condition, which could lead todifficulty complying with the protocol (at the discretion of the Site PI)
Medical history of a brain disorder other than the disorder causing dementia exceptfor headache.
Deemed ineligible by the Site PI for any other reason.
Study Design
Connect with a study center
Mayo Clinic in Florida
Jacksonville, Florida 32224
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.